Anti-Helicobacter pylori therapy followed by celecoxib on progression of gastric precancerous lesions

doi:10.3748/wjg.15.2731

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 15, Issue 22

This Article

Citation of this article

Corresponding Author of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (4191)

All Articles published online

The chart showing PDF series, HTML series, Figures (1-5) series, Tables (1-3) series.

Item

Count

PDF

377

HTML

3446

Figures (1-5)

212

Tables (1-3)

156

Sum=4191

Jun 14, 2009 (publication date) through Jul 23, 2024

Times Cited of This Article

Times Cited (29)

Journal Information of This Article

Publication Name

World Journal of Gastroenterology

ISSN

1007-9327

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Orignal Articles

World J Gastroenterol. Jun 14, 2009; 15(22): 2731-2738
Published online Jun 14, 2009. doi: 10.3748/wjg.15.2731

Full Size Figure Download Figure

Figure 5 Effects of celecoxib on PPARγ protein expression. Representative PPARγ expression in paraffin-embedded gastric tissue sections by immunostaining. (A1) pre-treatment, and (A2) post-treatment with celecoxib. Nuclear staining of PPARγ was markedly increased post-treatment with celecoxib. ^aP < 0.05.

Citation: Zhang LJ, Wang SY, Huo XH, Zhu ZL, Chu JK, Ma JC, Cui DS, Gu P, Zhao ZR, Wang MW, Yu J. Anti-Helicobacter pylori therapy followed by celecoxib on progression of gastric precancerous lesions. World J Gastroenterol 2009; 15(22): 2731-2738
URL: https://www.wjgnet.com/1007-9327/full/v15/i22/2731.htm
DOI: https://dx.doi.org/10.3748/wjg.15.2731